Biotransformation of Flavokawains A, B, and C, Chalcones from Kava (Piper methysticum), by Human Liver Microsomes

Journal of Agricultural and Food Chemistry

Volumn 63, Issue 28, 2015, Pages 6376-6385

  Zenger, Katharina ^a   Agnolet, Sara ^b   Schneider, Bernd ^b   Kraus, Birgit ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b MAX PLANCK INSTITUTE FOR CHEMICAL ECOLOGY   (Germany)

Author keywords

cardamonin; flavokawain; glucuronides; human liver microsomes; kava; metabolism; Piper methysticum

Indexed keywords

BIOMOLECULES; GLUCOSE; METABOLISM; PHYSIOLOGY;

CARDAMONIN; FLAVOKAWAIN; GLUCURONIDES; HUMAN LIVER MICROSOMES; KAVA; PIPER METHYSTICUM;

METABOLITES;

PIPER METHYSTICUM;

CHALCONE; CHALCONE DERIVATIVE; FLAVOKAWAIN A; FLAVOKAWAIN B; FLAVONOID; GLUCURONIDE; KAVA; URIDINE DIPHOSPHATE GLUCURONIC ACID;

ANALOGS AND DERIVATIVES; CHEMISTRY; HUMAN; LIVER MICROSOME; METABOLISM;

CHALCONE; CHALCONES; FLAVONOIDS; GLUCURONIDES; HUMANS; KAVA; MICROSOMES, LIVER; URIDINE DIPHOSPHATE GLUCURONIC ACID;

EID: 84937686116     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/acs.jafc.5b01858     Document Type: Article

References (35)

1. Gerhäuser, C.; Alt, A.; Heiss, E.; Gamal-Eldeen, A.; Klimo, K.; Knauft, J.; Neumann, I.; Scherf, H.-R.; Frank, N.; Bartsch, H. et al. Cancer Chemopreventive Activity of Xanthohumol, A Natural Product Derived from Hop Mol. Cancer Ther. 2002, 1, 959-969
2. Furusawa, J.; Funakoshi-Tago, M.; Mashino, T.; Tago, K.; Inoue, H.; Sonoda, Y.; Kasahara, T. Glycyrrhiza inflata-Derived Chalcones, Licochalcone A, Licochalcone B and Licochalcone D, Inhibit Phosphorylation of NF-κB p65 in LPS Signaling Pathway Int. Immunopharmacol. 2009, 9, 499-507 10.1016/j.intimp.2009.01.031
3. Freischmidt, A.; Jürgenliemk, G.; Kraus, B.; Okpanyi, S. N.; Müller, J.; Kelber, O.; Weiser, D.; Heilmann, J. Contribution of Flavonoids and Catechol to the Reduction of ICAM-1 Expression in Endothelial Cells by a Standardised Willow Bark Extract Phytomedicine 2012, 19, 245-252 10.1016/j.phymed.2011.08.065
4. Gaucher, M.; Dugé de Bernonville, T.; Lohou, D.; Guyot, S.; Guillemette, T.; Brisset, M.-N.; Dat, J. F. Histolocalization and Physico-Chemical Characterization of Dihydrochalcones: Insight into the Role of Apple Major Flavonoids Phytochemistry 2013, 90, 78-89 10.1016/j.phytochem.2013.02.009
5. Iwase, Y.; Takahashi, M.; Takemura, Y.; Ju-ichi, M.; Ito, C.; Furukawa, H.; Yano, M. Isolation and Identification of Two New Flavanones and a Chalcone from Citrus kinokuni Chem. Pharm. Bull. 2001, 49, 1356-1358 10.1248/cpb.49.1356
6. Yamamoto, T.; Yoshimura, M.; Yamaguchi, F.; Kouchi, T.; Tsuji, R.; Saito, M.; Obata, A.; Kikuchi, M. Anti-Allergic Activity of Naringenin Chalcone from a Tomato Skin Extract Biosci., Biotechnol., Biochem. 2004, 68, 1706-1711 10.1271/bbb.68.1706
7. Vogel, S.; Heilmann, J. Synthesis, Cytotoxicity, and Antioxidative Activity of Minor Prenylated Chalcones from Humulus lupulus J. Nat. Prod. 2008, 71, 1237-1241 10.1021/np800188b
8. Vogel, S.; Ohmayer, S.; Brunner, G.; Heilmann, J. Natural and Non-Natural Prenylated Chalcones: Synthesis, Cytotoxicity and Anti-Oxidative Activity Bioorg. Med. Chem. 2008, 16, 4286-4293 10.1016/j.bmc.2008.02.079
9. Ahmad, S.; Israf, D. A.; Lajis, N. H.; Shaari, K.; Mohamed, H.; Wahab, A. A.; Ariffin, K. T.; Hoo, W. Y.; Aziz, N. A.; Kadir, A. A. et al. Cardamonin, Inhibits pro-Inflammatory Mediators in Activated RAW 264.7 Cells and Whole Blood Eur. J. Pharmacol. 2006, 538, 188-194 10.1016/j.ejphar.2006.03.070
10. Lee, I.-S.; Lim, J.; Gal, J.; Kang, J. C.; Kim, H. J.; Kang, B. Y.; Choi, H. J. Anti-Inflammatory Activity of Xanthohumol Involves Heme Oxygenase-1 Induction via NRF2-ARE Signaling in Microglial BV2 Cells Neurochem. Int. 2011, 58, 153-160 10.1016/j.neuint.2010.11.008
11. Yadav, V. R.; Prasad, S.; Sung, B.; Aggarwal, B. B. The Role of Chalcones in Suppression of NF-κB-Mediated Inflammation and Cancer Int. Immunopharmacol. 2011, 11, 295-309 10.1016/j.intimp.2010.12.006
12. Orlikova, B.; Tasdemir, D.; Golais, F.; Dicato, M.; Diederich, M. Dietary Chalcones with Chemopreventive and Chemotherapeutic Potential Genes Nutr. 2011, 6, 125-147 10.1007/s12263-011-0210-5
13. Winter, E.; Locatelli, C.; Di Pietro, A.; Creczynski-Pasa, T. B. Recent Trends of Chalcones Potentialities as Antiproliferative and Antiresistance Agents Anticancer Agents Med. Chem. 2015, 15, 592-604
14. Modzelewska, A.; Pettit, C.; Achanta, G.; Davidson, N. E.; Huang, P.; Khan, S. R. Anticancer Activities of Novel Chalcone and Bis-Chalcone Derivatives Bioorg. Med. Chem. 2006, 14, 3491-3495 10.1016/j.bmc.2006.01.003
15. Gerhäuser, C. Broad Spectrum Anti-Infective Potential of Xanthohumol from Hop (Humulus lupulus L.) in Comparison with Activities of Other Hop Constituents and Xanthohumol Metabolites Mol. Nutr. Food Res. 2005, 49, 827-831 10.1002/mnfr.200500091
16. Nowakowska, Z. A Review of Anti-Infective and Anti-Inflammatory Chalcones Eur. J. Med. Chem. 2007, 42, 125-137 10.1016/j.ejmech.2006.09.019
17. Batovska, D. I.; Todorova, I. T. Trends in Utilization of the Pharmacological Potential of Chalcones Curr. Clin. Pharmacol. 2010, 5, 1-29 10.2174/157488410790410579
18. Meissner, O.; Häberlein, H. HPLC Analysis of Flavokavins and Kavapyrones from Piper methysticum Forst J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2005, 826, 46-49 10.1016/j.jchromb.2005.08.003
19. He, X. G.; Lin, L. Z.; Lian, L. Z. Electrospray High Performance Liquid Chromatography-Mass Spectrometry in Phytochemical Analysis of Kava (Piper methysticum) Extract Planta Med. 1997, 63, 70-74 10.1055/s-2006-957608
20. Singh, Y. N. Kava: An Overview J. Ethnopharmacol. 1992, 37, 13-45 10.1016/0378-8741(92)90003-A
21. Bilia, A. R.; Gallon, S.; Vincieri, F. F. Kava-Kava and Anxiety: Growing Knowledge about the Efficacy and Safety Life Sci. 2002, 70, 2581-2597 10.1016/S0024-3205(02)01555-2
22. Whitton, P. A.; Lau, A.; Salisbury, A.; Whitehouse, J.; Evans, C. S. Kava Lactones and the Kava-Kava Controversy Phytochemistry 2003, 64, 673-679 10.1016/S0031-9422(03)00381-9
23. Olsen, L. R.; Grillo, M. P.; Skonberg, C. Constituents in Kava Extracts Potentially Involved in Hepatotoxicity: A Review Chem. Res. Toxicol. 2011, 24, 992-1002 10.1021/tx100412m
24. Rowe, A.; Zhang, L. Y.; Ramzan, I. Toxicokinetics of Kava Adv. Pharmacol. Sci. 2011, 2011, 326724 10.1155/2011/326724
25. Kraft, K. Verwaltungsgericht Köln Kippt Das Kava-Verbot Z. Phytother. 2014, 35, 186-189 10.1055/s-0034-1371737
26. Zi, X.; Simoneau, A. R.; Flavokawain, A. Flavokawain A, a Novel Chalcone from Kava Extract, Induces Apoptosis in Bladder Cancer Cells by Involvement of Bax Protein-Dependent and Mitochondria-Dependent Apoptotic Pathway and Suppresses Tumor Growth in Mice Cancer Res. 2005, 65, 3479-3486 10.1158/0008-5472.CAN-04-3803
27. Tang, Y.; Simoneau, A. R.; Xie, J.; Shahandeh, B.; Zi, X. Effects of the Kava Chalcone Flavokawain A Differ in Bladder Cancer Cells with Wild-Type versus Mutant p53 Cancer Prev. Res. 2008, 1, 439-451 10.1158/1940-6207.CAPR-08-0165
28. Lin, C.-T.; Senthil Kumar, K. J.; Tseng, Y.-H.; Wang, Z.-J.; Pan, M.-Y.; Xiao, J.-H.; Chien, S.-C.; Wang, S.-Y. Anti-Inflammatory Activity of Flavokawain B from Alpinia pricei hayata J. Agric. Food Chem. 2009, 57, 6060-6065 10.1021/jf900517d
29. Kwon, D.-J.; Ju, S. M.; Youn, G. S.; Choi, S. Y.; Park, J. Suppression of iNOS and COX-2 Expression by Flavokawain A via Blockade of NF-κB and AP-1 Activation in RAW 264.7 Macrophages Food Chem. Toxicol. 2013, 58, 479-486 10.1016/j.fct.2013.05.031
30. Mohamad, A. S.; Akhtar, M. N.; Khalivulla, S. I.; Perimal, E. K.; Khalid, M. H.; Ong, H. M.; Zareen, S.; Akira, A.; Israf, D. A.; Lajis, N. et al. Possible Participation of Nitric Oxide/cyclic Guanosine Monophosphate/protein Kinase C/ATP-Sensitive K(+) Channels Pathway in the Systemic Antinociception of Flavokawin B Basic Clin. Pharmacol. Toxicol. 2011, 108, 400-405 10.1111/j.1742-7843.2010.00670.x
31. Mohamad, A. S.; Akhtar, M. N.; Zakaria, Z. A.; Perimal, E. K.; Khalid, S.; Mohd, P. A.; Khalid, M. H.; Israf, D. A.; Lajis, N. H.; Sulaiman, M. R. Antinociceptive Activity of a Synthetic Chalcone, Flavokawin B on Chemical and Thermal Models of Nociception in Mice Eur. J. Pharmacol. 2010, 647, 103-109 10.1016/j.ejphar.2010.08.030
32. 13C-Nuclear Magnetic Resonance Spectra of All Positional Isomers of Methyl Mono-O-Tetradecanoyl-α- and β-D-Glucopyranosides Chem. Pharm. Bull. 1980, 28, 208-219 10.1248/cpb.28.208
33. He, Y.-Q.; Yang, L.; Liu, Y.; Zhang, J.-W.; Tang, J.; Su, J.; Li, Y.-Y.; Lu, Y.-L.; Wang, C.-H.; Yang, L. et al. Characterization of Cardamonin Metabolism by P450 in Different Species via HPLC-ESI-Ion Trap and UPLC-ESI-Quadrupole Mass Spectrometry Acta Pharmacol. Sin. 2009, 30, 1462-1470 10.1038/aps.2009.127
34. Kohno, Y.; Kitamura, S.; Sanoh, S.; Sugihara, K.; Fujimoto, N.; Ohta, S. Metabolism of the α,β-Unsaturated Ketones, Chalcone and trans -4-Phenyl-3-buten-2-one, by Rat Liver Microsomes and Estrogenic Activity of the Metabolites Drug Metab. Dispos. 2005, 33, 1115-1123 10.1124/dmd.104.002634
35. Jirásko, R.; Holcapek, M.; Vrublová, E.; Ulrichová, J.; Simánek, V. Identification of New Phase II Metabolites of Xanthohumol in Rat in Vivo Biotransformation of Hop Extracts Using High-Performance Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry J. Chromatogr A 2010, 1217, 4100-4108 10.1016/j.chroma.2010.02.041